1272. Feasibility and Successful Enrollment in Proof-of-Concept Trials to Assess Safety and Efficacy of a Broadly Neutralizing Monoclonal Antibody, VRC01, to Prevent HIV-1 Acquisitionin in Uninfected Individuals
Srilatha Edupuganti(Emory University), Lawrence Corey(Fred Hutch Cancer Center), Myron S. Cohen(University of North Carolina at Chapel Hill), Paul Goepfert(University of Maryland, Baltimore), Allan C. deCamp(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Nidhi Kochar(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Maija Anderson(Fred Hutch Cancer Center), Simbarashe Takuva(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Emily Shava(Botswana Harvard AIDS Institute Partnership), Pamela Mukwekwerere(University of Zimbabwe), Kyle Marshall(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Shelly Karuna(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Martín Casapía(Asociación para la Conservación de la Cuenca Amazónica), Margarita Gomez Lorenzo, John R. Mascola(National Institute of Allergy and Infectious Diseases), Erica Lazarus(Norwegian Womens Public Health Association), P. Andrew(Family Health International 360), Jorge Sánchez(National University of San Marcos), David Burns(Norwegian Womens Public Health Association), Nyaradzo Mgodi(University of Zimbabwe), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Robert De La Grecca(Infectious Disease Research Institute)
Cited by 0
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
|New England Journal of Medicine|1990|1.3k